NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/24/2025
Back to search
Official data from USPTO
ALLISON INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALLISON INSTITUTE
ST13
US500000097975242Class
35, 36, 42, 44
Filing
97975242
Registration
7845095
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/24/2025
Trademark type
Word
Nice classes
35, 36, 42, 44
Filing date
03/25/2022
Registration date
06/24/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/24/2025
Last transaction
06/24/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/14/2023
First use in commerce
11/14/2023
Drawing code
4
Owner type
14
Owner location
Austin, TX, US
Examiner
GLUECK, CHRISTOPHER
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Board of Regents of the University of Texas System
Representatives
Robin Lightner Maisashvili FIBBE LIGHTNER LLP
Technical classification
Nice Classes
Class 35Class 36Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting collaboration within the scientificresearchpharmaceuticalmedical communities to achieve advances in healthcareincluding to accelerate the development and use of immunotherapy in treatment of disease
Class 36
Charitable fundraising services
Class 42
Medical research services; medical researchdevelopmenttechnical designtestinganalysis services in the field of immunobiologyimmunotherapyantibodiesoncology; consulting services in the field of immunobiologyimmunotherapyantibodiesoncology; medical research and development of antibodiestherapeutic productsvaccinesimmunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiologyimmunotherapyantibodies and oncology; biological research; laboratory research services in the fields of immunobiologyimmunotherapyantibodiesoncologycellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell researchcancerimmunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison servicesconsulting in the field of scientific research pertaining to clinical trials in the fields of health caremedicineimmunobiologyimmunotherapypharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; Pharmaceutical research services; Pharmaceutical research services relating to cancer
Class 44
Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiologyimmunotherapyoncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiologyimmunotherapyoncology and diseases; providing medical informationconsultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/02/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/02/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/09/2025
IUAF
USE AMENDMENT FILED
05/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/23/2025
EX4G
SOU EXTENSION 4 GRANTED
04/23/2025
EXT4
SOU EXTENSION 4 FILED
04/16/2025
EEXT
SOU TEAS EXTENSION RECEIVED
04/16/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/17/2024
EX3G
SOU EXTENSION 3 GRANTED
10/17/2024
EXT3
SOU EXTENSION 3 FILED
10/17/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/17/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/12/2024
EX2G
SOU EXTENSION 2 GRANTED
04/11/2024
EXT2
SOU EXTENSION 2 FILED
04/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/13/2023
EX1G
SOU EXTENSION 1 GRANTED
10/11/2023
EXT1
SOU EXTENSION 1 FILED
10/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/18/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2023
PUBO
PUBLISHED FOR OPPOSITION
02/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/11/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/11/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/11/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/11/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
12/12/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/05/2022
DRRR
DIVISIONAL REQUEST RECEIVED
11/01/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/29/2022
GNRT
NON-FINAL ACTION E-MAILED
08/29/2022
CNRT
NON-FINAL ACTION WRITTEN
08/29/2022
DOCK
ASSIGNED TO EXAMINER
08/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/30/2022
NWAP
NEW APPLICATION ENTERED
03/29/2022
Continuous trademark protection
Get notified about every new filing that threatens ALLISON INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.